Looking for clues from frogs, fish, and snails to fight off disease

May 31, 2012, University of Rochester Medical Center

In their effort to fight cancer and other threats to human health, researchers look to the birds, the bees – and to frogs, fish, and any number of species, studying how their natural defenses help protect them and what we might learn from them.

Such researchers from around North America will gather in Rochester next week for the 3rd North American Comparative Immunology Workshop at the University of Rochester Medical Center. They’ll trade notes about the disease-fighting capabilities of catfish, frogs, snails, sea squirts and other species, in an effort to learn more about stopping diseases that affect not only those animals but people as well.

The three-day workshop is being organized by Jacques Robert, Ph.D., associate professor of Microbiology and Immunology and the creator of the Jumping Frog Laboratory, an international resource that puts frogs in the forefront in the fight against diseases that threaten both humans and amphibians.

Robert himself is an expert on the of the frog, which develops much like a person’s but much faster – in just a couple of weeks, compared to many months for people.

In one line of research, scientists are trying to discover how the body can fight off cancerous tumors more effectively. Through work in frogs, they’ve learned that the body relies heavily on a specialized type of T cell to counter the tumor’s growth or even oust the tumor altogether.

“Learning more about how an organism like the frog identifies and fights tumors provides a good lead to see if there is a resource within the body that can be tapped to fight tumors in people more effectively,” said Robert.

At next week’s workshop, scientists will discuss how studies in catfish have uncovered previously unknown links between very different parts of the immune system – important clues for understanding how the body fights off cancer and other diseases.

Such work also offers clues to how organisms respond to emerging pathogens. In people, for instance, a small change to a long-known threat, flu, caused a worldwide pandemic just three years ago. Currently, amphibians are experiencing a vast die-off around the globe partly due to infections from a fungus (chytridiomycosis) and a virus (ranavirus), which had been present for decades but only recently threatened frog populations worldwide.

“How are these pathogens able to escape the frog’s immune system? Understanding the challenge that amphibians are facing will help us understand how a human pathogen might attack us, and to be better prepared to respond,” said Robert.

Two years ago, Robert was part of an international team that sequenced the more than 20,000 genes of an African clawed frog, Xenopus tropicalis. The accomplishment gave scientists a new tool to understand how our genes work at the most basic level. The team found that that frog has more than 1,700 genes very similar to genes in people that are related to conditions like , asthma, and heart disease.

At Rochester, Robert heads a unique international resource, the Xenopus laevis Research Resource for Immunobiology. The laboratory, funded by the National Institute of Allergy and Infectious Diseases, is the world’s most comprehensive resource specializing in the use of Xenopus for immunological research. The laboratory makes available to scientists around the globe tools such as reagents, antibodies, and other equipment and expertise. His lab has aided the research efforts of more than 100 other laboratories since it was created eight years ago.

Explore further: Study: Triple threat paints grim future for frogs

Related Stories

Study: Triple threat paints grim future for frogs

November 16, 2011
Frogs, salamanders and other amphibians may eventually have no safe haven left on the globe because of a triple threat of worsening scourges, a new study predicts.

Recommended for you

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.